Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label single-arm study of topical delgocitinib ointment in rosacea and rosacea-like dermatitis
jRCTs061210078Completed
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of delgocitinib in rosacea and dermatitis. Primary endpoint: Score of clinical manifestations (8-item composite). Started Jun 2022; status: completed.
02
Drugs
delgocitinib
03
Conditions
rosaceadermatitis
Beyond the preview
Go deeper on jRCTs061210078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061210078.